Transposon Therapeutics Receives Fast Track Designation for PSP Treatment

Graphic: Transposon Therapeutics Receives Fast Track Designation for PSP Treatment

Biotechnology company Transposon Therapeutics announced on May 21 that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for an intervention developed to treat progressive supranuclear palsy (PSP), an FTD disorder that primarily affects movement. The designation was granted to TPN-101, an orally administered drug that targets LINE-1, a virus-like…

Read More

June 24, 2024: VA Caregiver Support Annual Summit

AFTD staff will have an information table during the annual summit of the VA New Jersey Health Care System in East Orange. The event, which this year is titled “Beyond the Caregiving Role: Seeing the ‘Whole’ Caregiver,” will be held in the third floor auditorium in the East Orange VA Medical Center on June 24,…

Read More

VA Caregiver Support Annual Summit

AFTD staff will have an information table during the annual summit of the VA New Jersey Health Care System in East Orange. The event, which this year is titled “Beyond the Caregiving Role: Seeing the ‘Whole’ Caregiver,” is held in the third floor auditorium in the East Orange VA Medical Center.

Read More